Insulin-Like Growth Factor-1 Explored for Vitiligo Oxidative Stress Protection

Vitiligo is a chronic autoimmune skin condition characterized by the loss of pigment-producing cells called melanocytes, leading to white patches on the skin. Its complex development involves genetic factors, environmental triggers, and significant oxidative stress, which damages melanocytes. Previous research suggests Insulin-Like Growth Factor-1 (IGF-1) may protect melanocytes from this stress, but its specific role and levels in vitiligo patients' skin are not fully understood. This study aims to investigate the protective role of IGF-1 against oxidative stress in vitiligo patients.

As an ongoing study, specific results are not yet available. However, the researchers aim to uncover several key relationships. They plan to measure the levels of IGF-1 and IMA in both perilesional and distant skin of vitiligo patients and compare these levels to those in normal controls. They hypothesize that IGF-1 levels might be altered in vitiligo skin, potentially reflecting its protective role against oxidative damage. They also expect to see elevated IMA levels, indicating increased oxidative stress in affected areas. The primary objective is to investigate the relationship between IGF-1, as a potential protective factor against oxidative stress, and IMA, as a marker of oxidative stress, in vitiligo patients' skin. Furthermore, the study intends to correlate IMA levels with the psychological status of the patients, acknowledging the significant impact vitiligo can have on mental well-being.